Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	-24.44	-13.56	-15.84	-17.05	-108.78	-58.29
Depreciation & Amortization	2.98	5.38	6.73	8.82	10.15	9.2
Stock-Based Compensation	0.65	0.58	2.37	6.05	5.25	3.57
Other Adjustments	14.79	11.41	10.02	2.86	75.43	17.87
Change in Receivables	-5.6	-7.63	5.2	-7.15	6.53	1.54
Changes in Inventories	1.09	0.38	-4.82	-3.61	1.3	2.79
Changes in Accounts Payable	-0.38	0.29	-2.08	2.38	-7.68	-3.25
Changes in Accrued Expenses	-3.79	0.89	-9.16	3.61	-13.29	0.77
Changes in Other Operating Activities	0.38	0.34	6.2	-1.03	2.28	-0.18
Operating Cash Flow	-0.6	-1.94	-1.39	-5.13	-28.82	-25.96
Capital Expenditures	-0.1	-0.23	-0.33	-	-	-
Sale of Property, Plant & Equipment	-	0.67	-	-	-	-
Purchases of Intangible Assets	-	-3	-	-	-	-2.34
Payments for Business Acquisitions	-	-	-	-	-	-15.52
Proceeds from Business Divestments	-	-	-	-	-	15.72
Other Investing Activities	-	-	-	-0.12	-3.25	-0.64
Investing Cash Flow	-3.1	-2.56	-0.33	-0.12	-3.25	-2.78
Short-Term Debt Issued	5.06	6.67	0.83	-2.25	-	51.21
Short-Term Debt Repaid	-	-	-	-	-4.12	-53.98
Net Short-Term Debt Issued (Repaid)	5.06	6.67	0.83	-2.25	-4.12	-2.77
Long-Term Debt Issued	-	1.86	13	-	15	-
Long-Term Debt Repaid	-1.86	-1.86	-15.72	-0.1	-16.1	-
Net Long-Term Debt Issued (Repaid)	-1.86	-	-2.72	-0.1	-1.1	-
Issuance of Common Stock	14.84	14.84	3.47	15.58	11.69	40.15
Net Common Stock Issued (Repurchased)	14.84	14.84	3.47	15.58	11.69	40.15
Other Financing Activities	-8.05	-6.07	-2.84	-4.36	-4.94	-7.06
Financing Cash Flow	13.33	15.44	-1.26	8.87	1.53	30.31
Net Cash Flow	9.63	10.95	-2.98	3.63	-30.54	1.57
Free Cash Flow	-0.7	-2.17	-1.72	-5.13	-28.82	-25.96
FCF Margin	-1.11%	-3.26%	-2.63%	-4.78%	-29.82%	-39.56%
Free Cash Flow Per Share	-0.06	-0.34	-0.31	-1.54	-19.61	-31.01
Levered Free Cash Flow	-21.07	0.15	-21.2	-9.23	-121.25	-51.72
Unlevered Free Cash Flow	-8.39	-0.53	-4.73	-6.9	-117.04	-49.79

Updated Feb 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q